The Board of the Philadelphia Parking Authority has changed the date for the regularly scheduled May Board Meeting to Wednesday, May 31, 2017 at 10:00 am in the Board Room of the Authorityâs Headquarters, 701 Market Street, Suite 5400, Philadelphia, PA 19106.
Depo-Provera is the brand name of the drug medroxyprogesterone, which is an injection used to prevent pregnancy. A form of this medication may also be used to treat endometriosis (a condition where tissue that lines the uterus grows in other areas of the body). Depo-Provera is in a class of drugs known as progestins. It works by preventing the ovaries from releasing eggs and thinning the lining of the uterus.
Women who use Depo-Provera Contraceptive Injection may lose significant bone mineral density. Bone loss is greater with increasing duration of use and may not be completely reversible. It is unknown if use of Depo-Provera Contraceptive Injection during adolescence or early adulthood, a critical period of bone accretion, will reduce peak bone mass and increase the risk for osteoporotic fracture in later life.